Merck (MRK) shows mixed signals 📊. The stock rebounded from $76.46 to $78 on 4/17, but both 9-day and 21-day EMAs are declining, hinting at bearish pressure. RSI climbed from ~29 (oversold) to 35—still neutral, so more upside possible. Volume spiked on the uptick, suggesting buyer interest. However, looming lawsuits and tariff news add uncertainty. Short-term traders might ride the bounce, but long-term investors should wait for clearer trends or earnings results. 🧐 Hold for now, but watch EMAs for crossover signals!

Merck (MRK) shows mixed signals 📊. The stock’s downtrend is evident with both 9- and 21-day EMAs sloping downward, but today’s close above the open suggests minor bullish resilience. RSI at 36.3 hints at nearing oversold territory, though not there yet. Volume spiked today, possibly signaling capitulation or accumulation. News is noisy—earnings optimism clashes with lawsuits and tariff fears. 🧐 For now, it’s a hold—wait for RSI to dip below 30 or a bullish EMA crossover for clearer signals. #PatiencePays

Merck (MRK) has been volatile lately, with a bearish trend as both the 9 and 21-day EMAs slope downward 📉. The RSI recently dipped below 40 but is now hovering around 36—approaching oversold territory, which could hint at a near-term bounce. Volume spiked on April 9-10, suggesting heightened selling pressure. The legal headlines add uncertainty, but if the RSI rebounds from oversold levels, a short-term rally might follow. For now, it’s a hold—unless you’re betting on a lawsuit-driven dip. 🧐